HC ANDERSEN CAPITAL

ExpreS2ion Biotechnologies – Presentation of Q3 2025 Earnings Release

AUTHOR

Mie

DATE

13. October 2025

ExpreS2ion Biotechnologies – Presentation of Q3 2025 Earnings Release

ExpreS2ion Biotechnologies - Presentation of Q3 2025 Earnings Release 13 NovemberNov 2025 11:00 - 11:30Online Event

Information

ExpreS2ion Biotechnologies - Presentation of Q3 2025 Earnings Release 13 NovemberNov 2025 11:00 - 11:30

ExpreS2ion Biotechnologies - Presentation of Q3 2025 Earnings Release Online Event

Gubra – Præsentation af Q3 2025 handelsopdatering

Ascelia Pharma – Presentation of interim Q3 2025 report

Explore our services

INFORMATION

Bredgade 23B 2. sal
1260 København K
View on map
Phone: 28 74 66 40
CVR: 41474793

About

What we do

HC Andersen Capital was established in 2020 and is at the forefront of digital Investor Relations, amplifying market presence.

Our tailored services encompass IR and ESG advisory, Legal Support, cutting-edge digital solutions such as IR websites and IR distribution software, Commissioned Research, Corporate Finance advisory and more. We are proudly Certified Adviser on Nasdaq First North Copenhagen.

About us

What we do in short

Advisory

IR Services

Our Community

ExpreS2ion Biotechnologies – Presentation of Q3 2025 Earnings Release

ExpreS2ion Biotechnologies – Presentation of Q3 2025 Earnings Release

Information

Explore our services

INFORMATION

About

What we do

2024 - HC Andersen Capital